NAS:CTNM (USA)
Â
Class A Common Stock
$
16.76
-0.36 (-2.1%)
07:09 PM EST
New Key Statistics Module, Z-Score and F-Score
NAS:CTNM Key Ratios
| Market Cap $ M | 431.12 |
| Enterprise Value $ M | 222.84 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.03 |
| Price/Sales | 6.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 50.00 |
| EPS (TTM) $ | -0.07 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -171.00 |
| EV-to-EBIT | -7.02 |
| EV-to-EBITDA | -7.07 |
| PEG | -- |
| Shares Outstanding M | 25.72 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 58.92 |
| Current Ratio | 58.92 |
| ROA % (ttm) | -20.47 |
| ROE % (ttm) | -983.15 |
| ROIC % (ttm) | -880.50 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
CTNM Number of Guru Trades
CTNM Volume of Guru Trades
Gurus Latest Trades with NAS:CTNM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTNM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Contineum Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CTNM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers